Insulin tregopil
- Generic Name
- Insulin tregopil
- Drug Type
- Biotech
- CAS Number
- 874442-57-6
- Unique Ingredient Identifier
- 3UYC0OZ5ON
- Indication
code text here
Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients
Phase 2
Completed
- Conditions
- Type2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2018-02-13
- Last Posted Date
- 2020-05-15
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 143
- Registration Number
- NCT03430856
- Locations
- 🇮🇳
Diacon Hospital, Bangalore, Karnataka, India
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Phase 1
Terminated
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 20
- Registration Number
- NCT01035801
- Locations
- 🇮🇳
Bharti Research Institute of Diabetes and Endocrinology, Karnal, Hariyana, India
🇮🇳Bangalore Diabetes Hospital, Bangalore, Karnataka, India
🇮🇳Care Hospital, Hyderabad, Andhra Pradesh, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath